Clinical Trials in Mysore

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1125 matching records held by the registry are in this view. Synced 22 Sep 2026, 03:16 UTC

1125

Studies in scope

all four open statuses

610

Recruiting now

open to new participants

221

Lead sponsors

across recruiting studies

Top sites

Kolkata 54 Delhi 40 Bangalore 39 New Delhi 38 Mumbai 37

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Clear sponsor filter

Site location

All 76 locations

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

Indian sites

Start

Active, closed

Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease

NCT06851806Respiratory Syncytial Virus (RSV)

AstraZeneca

Not applicable

Hyderabad, Jhānsi, Kanpur, Kolkata, Mysore, Nagpur, Pune, Vidyanagar, Hubballi

2025-12-10

Active, closed

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

NCT05043090Papillary Renal Cell Carcinoma

AstraZeneca

Phase 3

148

Bangalore, Belagavi, Jaipur, Mysore, Nashik

2021-10-28

Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-india/city/mysore

Query this register directly

GET /api/trials?country=in&status=recruiting&format=json Try it now →

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.